Preparation, physicochemical characterization, and cell viability evaluation of long-circulating and pH-sensitive liposomes containing ursolic acid

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Caldeira De Araújo Lopes, Sávia ^a   Vinícius Melo Novais, Marcus ^a   Salviano Teixeira, Cláudia ^a   Honorato Sampaio, Kinulpe ^a   Tadeu Pereira, Márcio ^b   Ferreira, Lucas Antônio Miranda ^a   Braga, Fernão Castro ^a   Cristina Oliveira, Mônica ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b CENTRO DE DESENVOLVIMENTO DA TECNOLOGIA NUCLEAR   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; LIPOSOME; URSOLIC ACID; DRUG CARRIER; TRITERPENE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; DRUG FORMULATION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; PROSTATE CANCER; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; FEMALE; IC50; MALE; TUMOR CELL LINE; ULTRASTRUCTURE; DRUG EFFECT;

CELL LINE, TUMOR; CELL SURVIVAL; DRUG CARRIERS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; INHIBITORY CONCENTRATION 50; LIPOSOMES; MALE; PARTICLE SIZE; PHYSICOCHEMICAL PHENOMENA; TRITERPENES;

EID: 84883187354     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/467147     Document Type: Article

References (35)

1. Gautam R., Jachak S. M., Recent developments in anti-inflammatory natural products. Medicinal Research Reviews 2009 29 5 767 820 2-s2.0-69449105731 10.1002/med.20156
2. Kim S. H., Hong J. H., Lee Y. C., Ursolic acid, a potential PPARg agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma. European Journal of Pharmacology 2013 701 1-3 131 143
3. Jie L., Pharmacology of oleanolic acid and ursolic acid. Journal of Ethnopharmacology 1995 49 57 68 2-s2.0-29244491684 10.1016/0378-8741(95)01310-5
4. Somova L. O., Nadar A., Rammanan P., Shode F. O., Cardiovascular, antihyperlipidemic and antioxidant effects of oleanolic and ursolic acids in experimental hypertension. Phytomedicine 2003 10 2-3 115 121 2-s2.0-0037359363 10.1078/094471103321659807
5. Bonaccorsi I., Altieri F., Sciamanna I., Oricchio E., Grillo C., Contartese G., Galati E. M., Endogenous reverse transcriptase as a mediator of ursolic acid's anti-proliferative and differentiating effects in human cancer cell lines. Cancer Letters 2008 263 1 130 139 2-s2.0-41049100978 10.1016/j.canlet.2007.12.026
6. Manu K. A., Kuttan G., Ursolic acid induces apoptosis by activating p53 and caspase-3 gene expressions and suppressing NF- B mediated activation of bcl-2 in B16F-10 melanoma cells. International Immunopharmacology 2008 8 7 974 981 2-s2.0-43449137552 10.1016/j.intimp.2008.02.013
7. Xavier C. P. R., Lima C. F., Preto A., Seruca R., Fernandes-Ferreira M., Pereira-Wilson C., Luteolin, quercetin and ursolic acid are potent inhibitors of proliferation and inducers of apoptosis in both KRAS and BRAF mutated human colorectal cancer cells. Cancer Letters 2009 281 2 162 170 2-s2.0-67349181288 10.1016/j.canlet.2009.02.041
8. Kassi E., Sourlingas T. G., Spiliotaki M., Papoutsi Z., Pratsinis H., Aligiannis N., Moutsatsou P., Ursolic acid triggers apoptosis and Bcl-2 downregulation in MCF-7 breast cancer cells. Cancer Investigation 2009 27 7 723 733 2-s2.0-68849103157 10.1080/07357900802672712
9. Yan S.-L., Huang C.-Y., Wu S.-T., Yin M.-C., Oleanolic acid and ursolic acid induce apoptosis in four human liver cancer cell lines. Toxicology in Vitro 2010 24 3 842 848 2-s2.0-77649184736 10.1016/j.tiv.2009.12.008
10. Huang C.-Y., Lin C.-Y., Tsai C.-W., Yin M.-C., Inhibition of cell proliferation, invasion and migration by ursolic acid in human lung cancer cell lines. Toxicology in Vitro 2011 25 7 1274 1280 2-s2.0-84860392310 10.1016/j.tiv.2011.04.014
11. Kim K. H., Seo H. S., Choi H. S., Choi I. H., Shin Y. C., Ko S.-G., Induction of apoptotic cell death by ursolic acid through mitochondrial death pathway and extrinsic death receptor pathway in MDA-MB-231 cells. Archives of Pharmacal Research 2011 34 8 1363 1372 2-s2.0-80855124898 10.1007/s12272-011- 0817-5
12. Zhang H., Li X., Ding J., Delivery of ursolic acid (UA) in polymeric nanoparticles effectively promotes the apoptosis of gastric cancer cells through enhanced inhibition of cyclooxygenase 2 (COX-2). International Journal of Pharmaceutics 2013 441 1-2 261 268 10.1016/j.ijpharm.2012.11.034
13. Liu J., Oleanolic acid and ursolic acid: research perspectives. Journal of Ethnopharmacology 2005 100 1-2 92 94 2-s2.0-23044440041 10.1016/j.jep.2005. 05.024
14. Zhong Y., Wang J., Wang Y., Preparation and evaluation of liposome-encapsulated codrug LMX. International Journal of Pharmaceutics 2012 438 240 248
15. Vemuri S., Rhodes C. T., Preparation and characterization of liposomes as therapeutic delivery systems: a review. Pharmaceutica Acta Helvetiae 1995 70 2 95 111 2-s2.0-0029070813 10.1016/0031-6865(95)00010-7
16. Huwyler J., Drewe J., Krähenbühl S., Tumor targeting using liposomal antineoplastic drugs. International Journal of Nanomedicine 2008 3 1 21 29 2-s2.0-61649093243
17. Cavalli R., Caputo O., Gasco M. R., Preparation and characterization of solid lipid nanospheres containing paclitaxel. European Journal of Pharmaceutical Sciences 2000 10 4 305 309 2-s2.0-0034032145 10.1016/S0928- 0987(00)00081-6
18. Immordino M. L., Dosio F., Cattel L., Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. International Journal of Nanomedicine 2006 1 3 297 315 2-s2.0-34548482374
19. Torchilin V., Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. European Journal of Pharmaceutics and Biopharmaceutics 2009 71 3 431 444 2-s2.0-60749121731 10.1016/j.ejpb.2008.09.026
20. De Oliveira M. C., Rosilio V., Lesieur P., Bourgaux C., Couvreur P., Ollivon M., Dubernet C., pH-sensitive liposomes as a carrier for oligonucleotides: a physico-chemical study of the interaction between DOPE and a 15-mer oligonucleotide in excess water. Biophysical Chemistry 2000 87 2-3 127 137 2-s2.0-0034735678 10.1016/S0301-4622(00)00180-0
21. Simões S., Nuno Moreira J., Fonseca C., Düzgüneş N., Pedroso De Lima M. C., On the formulation of pH-sensitive liposomes with long circulation times. Advanced Drug Delivery Reviews 2004 56 7 947 965 2-s2.0-1942534972 10.1016/j.addr.2003.10.038
22. Carvalho A. D. Jr., Vieira F. P., De Melo V. J., Lopes M. T. P., Silveira J. N., Ramaldes G. A., Garnier-Suillerot A., Pereira-Maia E. C., De Oliveira M. C., Preparation and cytotoxicity of cisplatin-containing liposomes. Brazilian Journal of Medical and Biological Research 2007 40 8 1149 1157 2-s2.0-34547747859
23. Gullino P. M., Grantham F. H., Smith S. H., Haggerty A. C., Modifications of the acid-base status of the internal milieu of tumors. Journal of the National Cancer Institute 1965 34 6 857 869 2-s2.0-0001249721
24. Bangham A. D., Standish M. M., Watkins J. C., Diffusion of univalent ions across the lamellae of swollen phospholipids. Journal of Molecular Biology 1965 13 1 238 252 2-s2.0-0013793897
25. Mosmann T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 1983 65 1-2 55 63 2-s2.0-0021061819
26. Agência Nacional De Vigilância Sanitária, Guia para validação de métodos analíticos. Resoluç ão no. 899, de 20 de maio de 2003, http://www.anvisa.gov.br/legis/resol/ 2003/re/899-03re.htm
27. New R. R. C., Liposomes: A Pratical Approach 1990 New York, NY, USA Oxford University Press
28. Torchilin V. P., Targeted pharmaceutical nanocarriers for cancer therapy and imaging. The AAPS Journal 2007 9 2 E128 E147 2-s2.0-34249327294 10.1208/aapsj0902015
29. Yuan F., Dellian M., Fukumura D., Leunig M., Berk D. A., Torchilin V. P., Jain R. K., Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Research 1995 55 17 3752 3756 2-s2.0-0029150245
30. Wang X., Wang Y., Chen Z., Advances of cancer therapy by nanotechnology. Cancer Research and Treatment 2009 41 1 11
31. Puri A., Loomis K., Smith B., Lee J.-H., Yavlovich A., Heldman E., Blumenthal R., Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Critical Reviews in Therapeutic Drug Carrier Systems 2009 26 6 523 580 2-s2.0-77951690744
32. Lasic D. D., Novel applications of liposomes. Trends in Biotechnology 1998 16 7 307 321 2-s2.0-0031800381 10.1016/S0167-7799(98)01220-7
33. Yang T., Cui F.-D., Choi M.-K., Cho J.-W., Chung S.-J., Shim C.-K., Kim D.-D., Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation. International Journal of Pharmaceutics 2007 338 1-2 317 326 2-s2.0-34248638766 10.1016/j.ijpharm.2007.02.011
34. Johnsson M., Edwards K., Liposomes, disks and spherical micelles: aggregate structure in mixtures of gel phase phosphatidylcholines and poly(ethyleneglycol)-phospholipids. Biophysical Journal 2003 85 6 3839 3847 2-s2.0-0344551055
35. Ramos A. A., Lima C. F., Pereira M. L., Fernandes-Ferreira M., Pereira-Wilson C., Antigenotoxic effects of quercetin, rutin and ursolic acid on HepG2 cells: evaluation by the comet assay. Toxicology Letters 2008 177 1 66 73 2-s2.0-39549121695 10.1016/j.toxlet.2008.01.001